Scantox Neuro GmbH

Scantox Neuro, a full-service contract research organization (CRO), has been integrated into the Scantox Group in April 2024. The company performs preclinical research. Scantox Neuro is well known as a leading CRO for CNS drug development. The availability of the most predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes turn the company into the first choice for most research needs. Validated transgenic and non-transgenic in vitro and in vivo models cover most targets of Alzheimers-, Parkinsons-, Huntingtons disease, other neurodegenerative disorders and Orphan diseases. Check out our websites for detailed information: Scantox Group:...

Contract research organization (cro),cns research,neuropharmacology,alzheimer's disease,parkinson's disease,huntington's disease,transgenic research models,cns drug development,neurodegenrative disesae,in vitro research models,orphan diseases,and behavioral tests

Scantox neuro gmbh operates in the Research services industry.

Scantox neuro gmbh's HQ phone number is +45 5686 1500

Scantox neuro gmbh's revenue is 11m - 100m

Scantox neuro gmbh has 51 - 200 employees.